These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7992234)

  • 1. ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations.
    Bretschneider E; Glusa E; Schrör K
    Thromb Res; 1994 Aug; 75(3):233-42. PubMed ID: 7992234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation in recombinant-hirudin-anticoagulated blood.
    Glusa E
    Haemostasis; 1991; 21 Suppl 1():116-20. PubMed ID: 1909991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
    Zatta A; Zanetti A; Dejana E; Prosdocimi M
    Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of G619, a new platelet aggregation inhibitor.
    Yue TL; Smith EF; Ohlstein EH; Sulpizio A; Slivjak MJ; Rabinovici R; Sellers TS; Lynch KM; Poyser R; Feuerstein G
    Thromb Res; 1992 May; 66(4):331-47. PubMed ID: 1412200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
    Lin CH; Kuo YH; Lin YL; Teng CM
    J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of a thromboxane receptor antagonist (BM 13.505) on platelet hyperreactivity and thromboxane formation in cholesterol-fed rabbits.
    Löbel P; Schrör E; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S86-9. PubMed ID: 3073772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenaline-induced reactions of human platelets in hirudin plasma.
    Glusa E; Markwardt F
    Haemostasis; 1980; 9(3):188-92. PubMed ID: 7372203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S; Joseph S; Kakkar VV
    Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hirudin and platelets.
    Glusa E
    Semin Thromb Hemost; 1991 Apr; 17(2):122-5. PubMed ID: 1771409
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
    Francesconi M; Scapin M; Casonato A; Girolami A; Deana R
    Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet functions in recombinant hirudin-anticoagulated blood.
    Glusa E; Markwardt F
    Haemostasis; 1990; 20(2):112-8. PubMed ID: 2363746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H; Matthias FR; Lasch HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):761-8. PubMed ID: 6083951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists.
    Oda A; Miyakawa Y; Druker BJ; Ozaki K; Yabusaki K; Shirasawa Y; Handa M; Kato T; Miyazaki H; Shimosaka A; Ikeda Y
    Blood; 1996 Jun; 87(11):4664-70. PubMed ID: 8639835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.